Q2 2023 EPS Estimates for Agilent Technologies, Inc. (NYSE:A) Lifted by SVB Leerink

Agilent Technologies, Inc. (NYSE:AGet Rating) – Research analysts at SVB Leerink boosted their Q2 2023 earnings per share estimates for shares of Agilent Technologies in a report released on Monday, November 21st. SVB Leerink analyst P. Souda now expects that the medical research company will earn $1.30 per share for the quarter, up from their previous forecast of $1.26. SVB Leerink currently has a “Outperform” rating and a $160.00 price target on the stock. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.64 per share. SVB Leerink also issued estimates for Agilent Technologies’ Q4 2023 earnings at $1.62 EPS, FY2023 earnings at $5.63 EPS and FY2024 earnings at $6.09 EPS.

A number of other analysts have also commented on the stock. KeyCorp boosted their price target on shares of Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research note on Tuesday. Robert W. Baird raised their price target on shares of Agilent Technologies from $160.00 to $170.00 in a research report on Tuesday. Cowen lifted their price target on Agilent Technologies from $160.00 to $168.00 in a research note on Tuesday. Citigroup increased their price objective on Agilent Technologies from $145.00 to $150.00 and gave the stock a “neutral” rating in a research note on Tuesday. Finally, Evercore ISI lifted their target price on Agilent Technologies from $140.00 to $155.00 in a research report on Tuesday. Four equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $157.00.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $155.35 on Wednesday. Agilent Technologies has a twelve month low of $112.52 and a twelve month high of $162.62. The stock’s 50 day moving average is $133.99 and its 200-day moving average is $128.48. The company has a quick ratio of 1.41, a current ratio of 2.03 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $45.99 billion, a price-to-earnings ratio of 37.25, a PEG ratio of 2.78 and a beta of 1.06.

Agilent Technologies (NYSE:AGet Rating) last released its quarterly earnings data on Monday, November 21st. The medical research company reported $1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.14. Agilent Technologies had a net margin of 18.31% and a return on equity of 30.31%. The company had revenue of $1.85 billion for the quarter, compared to analysts’ expectations of $1.76 billion. During the same quarter in the prior year, the firm earned $1.21 EPS. The business’s revenue was up 11.4% on a year-over-year basis.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 25th. Investors of record on Tuesday, January 3rd will be paid a dividend of $0.225 per share. This represents a $0.90 dividend on an annualized basis and a dividend yield of 0.58%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.21. The ex-dividend date is Friday, December 30th. Agilent Technologies’s payout ratio is presently 20.14%.

Insider Buying and Selling

In related news, VP Padraig Mcdonnell sold 2,103 shares of the business’s stock in a transaction dated Wednesday, September 28th. The stock was sold at an average price of $122.89, for a total transaction of $258,437.67. Following the completion of the transaction, the vice president now directly owns 13,217 shares in the company, valued at $1,624,237.13. The transaction was disclosed in a document filed with the SEC, which is available through this link. In related news, VP Padraig Mcdonnell sold 2,103 shares of the stock in a transaction on Wednesday, September 28th. The stock was sold at an average price of $122.89, for a total value of $258,437.67. Following the transaction, the vice president now owns 13,217 shares of the company’s stock, valued at $1,624,237.13. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Michael Tang sold 7,545 shares of Agilent Technologies stock in a transaction dated Tuesday, November 22nd. The stock was sold at an average price of $153.90, for a total value of $1,161,175.50. Following the sale, the senior vice president now directly owns 46,499 shares of the company’s stock, valued at approximately $7,156,196.10. The disclosure for this sale can be found here. In the last quarter, insiders have sold 174,326 shares of company stock valued at $26,474,537.

Hedge Funds Weigh In On Agilent Technologies

Several institutional investors and hedge funds have recently made changes to their positions in the business. Bromfield Sneider Wealth Advisors purchased a new stake in Agilent Technologies in the 2nd quarter worth approximately $31,000. EverSource Wealth Advisors LLC lifted its holdings in Agilent Technologies by 34.8% in the third quarter. EverSource Wealth Advisors LLC now owns 298 shares of the medical research company’s stock worth $37,000 after buying an additional 77 shares during the period. Edge Capital Group LLC boosted its position in Agilent Technologies by 53.0% during the 3rd quarter. Edge Capital Group LLC now owns 303 shares of the medical research company’s stock valued at $37,000 after acquiring an additional 105 shares in the last quarter. Guardian Wealth Advisors LLC purchased a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $42,000. Finally, CVA Family Office LLC boosted its position in shares of Agilent Technologies by 722.2% during the third quarter. CVA Family Office LLC now owns 370 shares of the medical research company’s stock valued at $45,000 after purchasing an additional 325 shares in the last quarter.

Agilent Technologies Company Profile

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Featured Stories

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.